BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 6359423)

  • 1. Quantitative assessment of deranged hepatic function: a missed opportunity?
    Bircher J
    Semin Liver Dis; 1983 Nov; 3(4):275-84. PubMed ID: 6359423
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antipyrine excretion and aminopyrine breath test: use and significance in the assessment of liver function].
    Gugler R
    Z Gastroenterol; 1987 Mar; 25 Suppl 2():51-6. PubMed ID: 3590907
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinico-statistical evaluation of the simultaneous clearance of sulfobromophthalein and galactose in chronic liver diseases].
    Rossi L; Innocenti P; Milani A; Bombardieri G
    Quad Sclavo Diagn; 1983 Jun; 19(2):271-84. PubMed ID: 6676775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Quantification of the drug-metabolizing enzyme system in liver diseases: a comparison between antipyrine saliva clearance and the aminopyrine breath test].
    von Mandach U; Jost G; Preisig R
    Schweiz Med Wochenschr; 1985 May; 115(19):651-8. PubMed ID: 3923620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Liver tests and tests of liver function (author's transl)].
    Bircher J; Colombo JP
    Ther Umsch; 1978 Sep; 35(9):701-6. PubMed ID: 360471
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative evaluation of tolerance tests with sulfobromophthalein and with galactose in chronic liver diseases. (Value and limitations of the discriminating analyses used in the 2 tests for diagnosis of hepatic cirrhosis)].
    Coltorti M; Di Simone A; Budillon G; Carrella M; Oriani G
    Policlinico Med; 1968; 75(4):189-215. PubMed ID: 5708459
    [No Abstract]   [Full Text] [Related]  

  • 7. Monitoring hepatic function.
    Zaloga GP; Prough DS
    Crit Care Clin; 1988 Jul; 4(3):591-603. PubMed ID: 3063353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic procedures in the evaluation of hepatic diseases. Functional evaluation of the hepatocyte.
    Tygstrup N; Vilstrup H
    Lab Res Methods Biol Med; 1983; 7():17-41. PubMed ID: 6353103
    [No Abstract]   [Full Text] [Related]  

  • 9. Non-invasive assessment of liver function: trying not to miss an opportunity.
    Giannini EG; Testa R
    Aliment Pharmacol Ther; 2004 Apr; 19(7):827-8. PubMed ID: 15043524
    [No Abstract]   [Full Text] [Related]  

  • 10. Fractional clearance of bromosulfonephthalein and metabolic clearance of antipyrine. Correlative study in liver diseases.
    Couet C; Brissot P; Messner M; Delamaire D; Gie S; Bourel M
    Ann Gastroenterol Hepatol (Paris); 1984; 20(1):1-6. PubMed ID: 6529154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hepatic clearance of sulfobromophthalein administered in small doses in subjects with hepatobiliary diseases].
    Cravario A; Molino G; Giangrandi E
    Minerva Gastroenterol; 1966; 12(4):135-41. PubMed ID: 5993623
    [No Abstract]   [Full Text] [Related]  

  • 12. [Caffeine--an ubiquitous indicator of liver function].
    Renner E; Wahländer A; Huguenin P; Wietholtz H; Preisig R
    Schweiz Med Wochenschr; 1983 Aug; 113(31-32):1074-81. PubMed ID: 6623026
    [No Abstract]   [Full Text] [Related]  

  • 13. Abnormalities in liver function and morphology and impaired aminopyrine metabolism in hereditary hepatic porphyrias.
    Ostrowski J; Kostrzewska E; Michalak T; Zawirska B; Medrzejewski W; Gregor A
    Gastroenterology; 1983 Nov; 85(5):1131-7. PubMed ID: 6618105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of bromsulfane-I131 for diagnosis of diseases of the hepatobiliary system].
    Zaĭtseva EI; Khokhlova LT
    Med Radiol (Mosk); 1978 Apr; 23(4):72-5. PubMed ID: 351322
    [No Abstract]   [Full Text] [Related]  

  • 15. [Liver metabolism of indocyanine green and aminopyrine in liver cirrhosis: relations with functioning liver cell mass].
    Bolognesi M; Merkel C; Angeli P; Caregaro L; Gatta A
    Minerva Med; 1988 Dec; 79(12):1035-41. PubMed ID: 3211355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the bromsulphthalein and galactose elimination test in patients with either chronic bowel inflammation or alcoholic liver disease.
    Nilsson LH; Hultman E
    Scand J Gastroenterol; 1974; 9(3):319-23. PubMed ID: 4850181
    [No Abstract]   [Full Text] [Related]  

  • 17. [Evaluation of disorders of portal and total hepatic blood flow in patients with chronic diffuse liver diseases].
    Duvnjak M; Zivković R; Ivancević D; Rotkvić I; Sikirić P; Anić T
    Acta Med Iugosl; 1989; 43(4):237-45. PubMed ID: 2697132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aminopyrine breath test: development of a 13C-breath test for quantitative assessment of liver function in humans.
    Mion F; Queneau PE; Rousseau M; Brazier JL; Paliard P; Minaire Y
    Hepatogastroenterology; 1995; 42(6):931-8. PubMed ID: 8847048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of famotidine on hepatic hemodynamics and peptic ulcer.
    Ohnishi K; Saito M; Nomura F; Okuda K; Suzuki N; Ohtsuki T; Goto N; Takashi M
    Am J Gastroenterol; 1987 May; 82(5):415-8. PubMed ID: 2883883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The aminopyrine breath test.
    Perri F; Pastore M; Annese V; Andriulli A
    Ital J Gastroenterol; 1994; 26(6):306-17. PubMed ID: 7949268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.